Cargando…

Achieving Effective and Efficient Basal Insulin Optimal Management by Using Mobile Health Application (APP) for Type 2 Diabetes Patients in China

AIM: To evaluate the effectiveness of the mobile health application (APP) education in basal insulin optimal management program for insulin-naive type 2 diabetes (T2D) patients in China. METHODS: The basal insulin optimal management program was launched in 297 hospitals in China, throughout the six...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Xiaoling, Zhang, Fang, Lin, Chu, Zhang, Xiaomei, Wang, Zhufeng, Xing, Huifang, Nie, Lin, Han, Xueyao, Ji, Linong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185643/ https://www.ncbi.nlm.nih.gov/pubmed/32368124 http://dx.doi.org/10.2147/DMSO.S244826

Ejemplares similares

Cardiovascular risk profile and clinical characteristics of diabetic patients: a cross-sectional study in China
por: Lyu, Fang, et al.
Publicado: (2022)

Sex differences in the prevalence of obesity in 800,000 Chinese adults with type 2 diabetes
por: Lv, Fang, et al.
Publicado: (2021)

Basal insulin titration by the app
por: Vangoitsenhoven, Roman, et al.
Publicado: (2023)

Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Cai, Xiaoling, et al.
Publicado: (2021)

Analysis of Insulin Doses of Chinese Type 2 Diabetic Patients with Intensive Insulin Treatment
por: Cai, Xiaoling, et al.
Publicado: (2012)

A pragmatic study of mid‐mixture insulin and basal insulin treatment in patients with type 2 diabetes uncontrolled with oral antihyperglycaemic medications: A lesson from real‐world experience
por: Zhang, Xiaomei, et al.
Publicado: (2020)

Where to Initiate Basal Insulin Therapy: Inpatient or Outpatient Department? Real-World Observation in China
por: Chen, Minyuan, et al.
Publicado: (2022)

Factors and outcomes associated with discontinuation of basal insulin therapy in patients with type 2 diabetes mellitus
por: Zhang, Puhong, et al.
Publicado: (2020)

Mobile Mental Health Apps in China: Systematic App Store Search
por: Yin, Huifang, et al.
Publicado: (2020)

Mobile app analytics: optimize your apps with user experience monitoring
por: Beer, Wolfgang
Publicado: (2016)

Effectiveness, safety, initial optimal dose, and optimal maintenance dose range of basal insulin regimens for type 2 diabetes: A systematic review with meta‐analysis
por: Luo, Yingying, et al.
Publicado: (2023)

Reduction of C-reactive protein, low-density lipoprotein cholesterol, and its relationship with cardiovascular events of different lipid-lowering therapies: A systematic review and meta-analysis of randomized controlled trials
por: Yang, Wenjia, et al.
Publicado: (2022)

Age, sex, disease severity, and disease duration difference in placebo response: implications from a meta-analysis of diabetes mellitus
por: Lin, Chu, et al.
Publicado: (2020)

The Body Weight Alteration and Incidence of Neoplasm in Patients With Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
por: Lin, Chu, et al.
Publicado: (2020)

Predicting the Optimal Basal Insulin Infusion Pattern in Children and Adolescents on Insulin Pumps
por: Holterhus, Paul-Martin, et al.
Publicado: (2013)

Estimation of atherosclerotic cardiovascular disease risk in type 2 diabetes
por: Cai, Xiaoling, et al.
Publicado: (2022)

High performance mobile Web: best practices for optimizing mobile Web apps
por: Firtman, Maximiliano R
Publicado: (2016)

SGLT2 inhibitors and lower limb complications: an updated meta‐analysis
por: Lin, Chu, et al.
Publicado: (2021)

Correction to: SGLT2 inhibitors and lower limb complications: an updated meta-analysis
por: Lin, Chu, et al.
Publicado: (2021)

The Biological Disease-Modifying Antirheumatic Drugs and the Risk of Cardiovascular Events: A Systematic Review and Meta-Analysis
por: Hu, Suiyuan, et al.
Publicado: (2021)

The Urinary Glucose Excretion by Sodium–Glucose Cotransporter 2 Inhibitor in Patients With Different Levels of Renal Function: A Systematic Review and Meta-Analysis
por: Hu, Suiyuan, et al.
Publicado: (2022)

Insulin Degludec, The New Generation Basal Insulin or Just another Basal Insulin?
por: Nasrallah, Sami N., et al.
Publicado: (2012)

First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia
por: TSAI, Shih-Tzer, et al.
Publicado: (2011)

The clinical implications of fasting serum insulin levels in patients with insulin-treated type 2 diabetes: a cross-sectional survey
por: Zhou, Lingli, et al.
Publicado: (2023)

Rs4074134 Near BDNF Gene Is Associated with Type 2 Diabetes Mellitus in Chinese Han Population Independently of Body Mass Index
por: Han, Xueyao, et al.
Publicado: (2013)

Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian
por: Cai, Xiaoling, et al.
Publicado: (2013)

Clinical Characteristics of Young Type 2 Diabetes Patients with Atherosclerosis
por: Yang, Wenjia, et al.
Publicado: (2016)

P38 Plays an Important Role in Glucolipotoxicity-Induced Apoptosis in INS-1 Cells
por: Zhou, Lingli, et al.
Publicado: (2014)

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real‐world setting
por: Meneghini, Luigi F., et al.
Publicado: (2019)

Effect of Hemoglobin A1c Reduction or Weight Reduction on Blood Pressure in Glucagon‐Like Peptide‐1 Receptor Agonist and Sodium‐Glucose Cotransporter‐2 Inhibitor Treatment in Type 2 Diabetes Mellitus: A Meta‐Analysis
por: Hu, Mengdie, et al.
Publicado: (2020)

Concentrated insulins: the new basal insulins
por: Lamos, Elizabeth M, et al.
Publicado: (2016)

Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China
por: Zhang, Puhong, et al.
Publicado: (2022)

Cardiorespiratory Improvements Achieved by American College of Sports Medicine’s Exercise Prescription Implemented on a Mobile App
por: Rospo, Gianluca, et al.
Publicado: (2016)

Comparison of the Effect of Glycemic Control in Type 2 Diabetes Outpatients Treated With Premixed and Basal Insulin Monotherapy in China
por: Liu, Guangxu, et al.
Publicado: (2018)

Age at Diagnosis and C-Peptide Level Are Associated with Diabetic Retinopathy in Chinese
por: Cai, Xiaoling, et al.
Publicado: (2014)

Associated Factors with Biochemical Hypoglycemia during an Oral Glucose Tolerance Test in a Chinese Population
por: Cai, Xiaoling, et al.
Publicado: (2017)

Novel Once-Weekly Basal Insulin Fc Achieved Similar Glycemic Control With a Safety Profile Comparable to Insulin Degludec in Patients With Type 1 Diabetes
por: Kazda, Christof M., et al.
Publicado: (2023)

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA
por: Blonde, Lawrence, et al.
Publicado: (2018)

A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience
por: Zeng, Tianshu, et al.
Publicado: (2021)

Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
por: Lu, Xiaomei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_truljc575hkcio73304cn3ndj5